Plaque Rupture and Thrombosis
Davide Capodanno, Full Professor of Cardiology at the University of Catania, shared on X:
“Plaque rupture with thrombosis drives ACS, and thin-cap fibroatheroma is the archetypal high-risk plaque. There are consistent features of vulnerability across imaging modalities (large plaque burden, small MLA, TCFA, high LCBI, positive remodelling, etc.), with risk increasing when multiple features coexist. Yet absolute event rates remain low, consistent with pathology data showing most plaque ruptures are clinically silent.
So should we prophylactically stent high-risk plaques? According to this Viewpoint, completed trials (PROSPECT ABSORB, PREVENT) suggest no durable reduction in death or MI versus optimal medical therapy—benefits are limited to fewer revascularisations, at the cost of many unnecessary PCIs. With modern medical therapy, a wait-and-see strategy appears safe, avoiding most interventions without adverse consequences. For now, data favor surveillance and aggressive medical therapy over preventive PCI.
READ THE VIEWPOINT HERE.
Stay updated with Hemostasis Today.
-
Apr 19, 2026, 11:34Jessica Garcia: Opportunity to Speak at the HFA about Hemophilia and Bleeding Disorders
-
Apr 19, 2026, 11:29Proud to Be a Member of The International ITP Alliance – ITP Australia and New Zealand
-
Apr 19, 2026, 11:16Shriram Varadharajan: Closing a Meaningful Chapter in Radiology and Stroke Care Leadership
-
Apr 19, 2026, 11:06Matías J Alet: Had the Opportunity to Conduct 2 World Stroke Organization Stroke Center Recertification Visits
-
Apr 19, 2026, 10:54Mavis Agnes Kisakye: Transforming Hemophilia Awareness in Uganda Through Community Engagement and Early Recognition
-
Apr 19, 2026, 10:47Danny Hsu: Unlocking The Real-World Potential of DOACs in Paediatric Thrombosis
-
Apr 19, 2026, 10:39Purusotham Chippala: Demystifying the Research Process in Physiotherapy after Stroke
-
Apr 19, 2026, 10:23Leo Nicolai: Expanding Role of Platelets in Inflammation
-
Apr 19, 2026, 10:18Nishith Patel: PhD or Masters Opportunity in Aortic Disease Research at the University of Auckland